Table 2 Proposed Choosing Wisely ®... | American Society of Hematology

Table 2

Proposed Choosing Wisely^® recommendations that overlapped with prior campaigns

Recommendation	Recommended by	Excluded from ASH Choosing Wisely^®campaign?	Reference
Do not use white cell stimulating factors…for patients with <20% risk of febrile neutropenia	ASCO	Yes	32
Avoid transfusions for arbitrary hemoglobin thresholds in the absence of symptoms of active coronary disease, heart failure, or stroke	SHM	No	39
Do not perform repetitive CBC and chemistry testing in the face of clinical and laboratory stability	SHM	Yes	39
Do not image for suspected pulmonary embolism without moderate or high pre-test probability	ACR	Yes	40

Recommendation	Recommended by	Excluded from ASH Choosing Wisely^®campaign?	Reference
Do not use white cell stimulating factors…for patients with <20% risk of febrile neutropenia	ASCO	Yes	32
Avoid transfusions for arbitrary hemoglobin thresholds in the absence of symptoms of active coronary disease, heart failure, or stroke	SHM	No	39
Do not perform repetitive CBC and chemistry testing in the face of clinical and laboratory stability	SHM	Yes	39
Do not image for suspected pulmonary embolism without moderate or high pre-test probability	ACR	Yes	40

ASCO indicates American Society of Clinical Oncology; SHM, Society of Hospital Medicine; ACR, American College of Radiology; and CBC, complete blood count.